Summary: A micromethod is described for the determination of glucose in 20 μΐ of skin-puncture blood for the DuPont aca. For the determination of glucose we prefer whole blood which is deproteinised with uranyl acetate. Some modification of test conditions are programmed into the computer II. The emergency analysis of supernatant on the aca then gives the same values as the Technicon Autoanalyzer II, using glucose dehydrogenase for routine analyses. The aca readout is linearly related to glucose concentrations up to 60 mmol/1.
Introduction
We claim that the determination of glucose in skinpuncture (capillary) blood is superior to the determination of glucose in serum or plasma; only the former method is physiologically sound and logical (1, 2, 3) .
The original aca glucose method is based on the analysis of 40 μΐ serum using the hexokinase glucose-6-phosphate dehydrogenase-method (4) . In order to prevent systematic differences in our results (5, 6) and different ways of taking samples, the aca had to be integrated into our system of sampling. Apparently two different approaches are possible:
1. Deproteinisation of the samples with acidic reagents (e.g. perchloric acid or perchloric acid/perchlprate) or 2. deproteinisation with neutral reagents (e.g. uranyl acetate)
Our group preferred the second way, which appeared easier, while another group independently verified the first modification (7) using 50 μΐ of whole blood, as we heard later.
Here we describe a method permitting determination of glucose in only 20 μΐ of whole blood on the DuPont aca.
Materials and Methods
Procedure 20 μΐ of skin-puncture blood were deproteinised with 500 μΐ of uranyl acetate solution (1.9 mmol/1) as described elsewhere (3). After centrifugation (7500 g y l min) the supernatant was ready for analysis, either in the aca or with the glucose dehydrogenase method on the Autoanalyzer II. 
Results

Linearity and Accuracy
Linearity exists in the range of 0-60 mmol/1 glucose as determined with glucose standards at levels of 0; 1.4, 2.8,9.7, 16.7, 27.8, 38.9,55.6 mmol/1. The method yields a correlation coefficient of 0.999 with a regression line of: y (aca) = 0.99x (standard) + 0.06.
Accuracy was tested with commercially available sera. Table 1 lists the sera investigated and shows our results.
Interfering Substances
Experiments have shown that there is less interference caused by hemolytic or icteric specimens in the new method than in the original aca version. Hemolyzed blood shows no significant interference up to 2.0 g/dl hemoglobin per sample. Higher concentrations of hemoglobin may give falsely depressed values. Icteric samples show no significant interference up to 680 Aimol/1 bilirubin per sample and lipemic samples can be analysed without significant interference up to 46 mmol/1 serum triglycerides. Serum protein concentrations from 40 g/1 up to 120 g/1 show no significant influence on the results. Lower protein concentrations may cause falsely elevated values. Table 2 indicates good results for within-run and day-today precision. The day-to-day imprecision encloses data from five different lot nos. of test packs and is nearly the same as that of the Autoanalyzer II.
Precision
Comparison of Methods
Results obtained by the present method were directly compared with those obtained by the glucose dehydrogenase method on the Technicon Autoanalyzer II (3, 8) . Standard deviation of y about x: s yjc = 0.698 mmol/1. Correlation coefficient: r = 0.994. T-test: t = 0.013, critical t value at P = 0.05 is 1.98; at P = 0.01 is 2.36.
Discussion
We have evaluated a microdetermination of glucose for the DuPont aca based on 20 μΐ of whole, skin-puncture blood. There are considerable practical advantages in our method: The volume of samples is minimal and easy to get, even from newborn children; no specially trained personel are required.
20 /il of sample reduce systematic errors due to deproteinisation (volume displacement effects) to a neglectable amount of 0.3%, thus permitting a cali- bration of the aca with usual protein-containing materials. Thus we can avoid determination of special "aca-values" for reference materials as described in I.e. (7) . Such bottle values have to be obtained by split sample comparison with a reference method, and they may cause uncertainties.
In our opinion the choice of uranyl acetate instead of acidic reagents for deproteinisation facilitates the adaption of the aca to the described modification: Less changes in the lacing diagramm of computer II have to be carried out and no special buffer solutions have to be prepared, which may cause complications with new aca tests requiring a diluent 6. Last, but not least, neither acidic nor corrosive reagents are aspirated by the aca in our modification.
The clinical validy of the method is documented by an increased range of linearity compared to (4,7), good coefficients of variation even at low, pathological levels, less interference due to glycolysis by red and white blood cells, icteric or lipemic samples, and results which show no systematic differences to an Autoanalyzer II method based on glucose dehydrogenase.
